CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Sonoma Pharma - SNOA CFD

    -
    0%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 -
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    关键数据
    前收盘价* N/A
    开仓* N/A
    1 年变化* N/A
    日范围* N/A
    52 周范围 0.76-4.19
    平均交易量（10 天） 21.15K
    平均交易量（3 个月) 3.03M
    市值 4.45M
    市盈率 -100.00K
    流通股 4.65M
    收入 12.56M
    EPS -2.19
    股息（收益率 %） N/A
    贝塔 1.15
    下一个财报发布日期 Jul 11, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low

    Sonoma Pharma Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Tuesday, July 11, 2023

    时间（协调世界时） (UTC)

    20:00

    国家/地区

    US

    事件

    Q4 2023 Sonoma Pharmaceuticals Inc Earnings Release
    Q4 2023 Sonoma Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    Wednesday, August 9, 2023

    时间（协调世界时） (UTC)

    20:00

    国家/地区

    US

    事件

    Q1 2024 Sonoma Pharmaceuticals Inc Earnings Release
    Q1 2024 Sonoma Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    Friday, September 15, 2023

    时间（协调世界时） (UTC)

    20:00

    国家/地区

    US

    事件

    Sonoma Pharmaceuticals Inc Annual Shareholders Meeting
    Sonoma Pharmaceuticals Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    时间（协调世界时） (UTC)

    21:00

    国家/地区

    US

    事件

    Q2 2024 Sonoma Pharmaceuticals Inc Earnings Release
    Q2 2024 Sonoma Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 12.628 18.629 17.928 18.97 16.658
    收入 12.628 18.629 17.928 18.97 16.658
    收入成本，共计 8.417 11.847 9.806 10.09 9.348
    毛利 4.211 6.782 8.122 8.88 7.31
    总营业费用 17.792 22.078 25.318 30.228 30.847
    销售/一般/行政费用，总计 9.755 9.453 14.173 18.62 19.924
    研究与开发 0.125 0.555 1.339 1.518 1.575
    营业收入 -5.164 -3.449 -7.39 -11.258 -14.189
    利息收入（费用），非经营净值 -0.01 0.004 0.034 0.157 0.218
    其他，净值 -0.394 -0.594 0.24 -0.239 -0.307
    税前净收入 -5.418 -3.902 -3.544 -11.34 -14.278
    税后净收入 -5.086 -4.615 -3.573 -11.798 -14.328
    未计算非常项目前的净收益 -5.086 -4.615 -3.573 -11.798 -14.328
    非常规项目总计 0 0.665 0.265
    净收入 -5.086 -3.95 -3.308 -11.798 -14.328
    普通股股东可获收益 (不含非经常性项目) -5.086 -4.615 -3.573 -11.798 -14.328
    普通股股东可获收益 (含非經常性項目) -5.086 -3.95 -3.308 -11.798 -14.328
    摊薄净收入 -5.086 -3.95 -3.308 -11.798 -14.328
    摊薄后加权平均股 2.653 1.996 1.477 0.924 0.503
    扣除特别项目的每股摊薄盈利 -1.91708 -2.31212 -2.41909 -12.7684 -28.4851
    每股正常摊薄盈利 -2.07755 -2.28412 -3.99106 -12.7684 -28.4851
    Gain (Loss) on Sale of Assets 0.15 0.137 3.572
    异常费用（收入） -0.505 0.223
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    总收入 2.944 3.331 3.983 2.298 2.902
    收入 2.944 3.331 3.983 2.298 2.902
    收入成本，共计 2.102 1.999 2.32 2.222 1.685
    毛利 0.842 1.332 1.663 0.076 1.217
    总营业费用 4.778 4.062 4.838 4.635 3.86
    销售/一般/行政费用，总计 2.665 2.067 2.295 3.152 2.135
    研究与开发 0 0 0.006 0.004 0.026
    异常费用（收入） 0.011 -0.004 0.217 -0.743 0.014
    营业收入 -1.834 -0.731 -0.855 -2.337 -0.958
    利息收入（费用），非经营净值 0.001 0.003 0 -0.009 0.003
    Gain (Loss) on Sale of Assets 0.001 0 0 0
    其他，净值 -0.073 -0.189 -0.067 -0.936 0.011
    税前净收入 -1.905 -0.917 -0.922 -3.282 -0.944
    税后净收入 -1.939 -1.017 -0.887 -2.944 -0.944
    未计算非常项目前的净收益 -1.939 -1.017 -0.887 -2.944 -0.944
    非常规项目总计 0 0
    净收入 -1.939 -1.017 -0.887 -2.944 -0.944
    普通股股东可获收益 (不含非经常性项目) -1.939 -1.017 -0.887 -2.944 -0.944
    普通股股东可获收益 (含非經常性項目) -1.939 -1.017 -0.887 -2.944 -0.944
    摊薄净收入 -1.939 -1.017 -0.887 -2.944 -0.944
    摊薄后加权平均股 3.107 3.101 3.101 3.091 3.08
    扣除特别项目的每股摊薄盈利 -0.62407 -0.32796 -0.28604 -0.95244 -0.30649
    每股正常摊薄盈利 -0.62198 -0.3288 -0.24055 -1.10869 -0.30195
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 16.43 12.983 12.283 12.496 16.254
    现金和短期投资 7.396 4.22 3.691 3.689 10.066
    现金等价物 7.396 4.22 3.691 3.689 10.066
    应收账款总额，净额 4.778 4.656 5.278 4.444 1.752
    Accounts Receivable - Trade, Net 2.407 2.806 3.973 3.481 1.537
    Total Inventory 2.663 2.53 2.181 3.409 2.865
    Prepaid Expenses 1.375 1.368 0.951 0.731 1.332
    Other Current Assets, Total 0.218 0.209 0.182 0.223 0.239
    Total Assets 18.845 14.987 14.561 14.448 19.206
    Property/Plant/Equipment, Total - Net 0.879 1.129 0.724 0.727 1.136
    Property/Plant/Equipment, Total - Gross 2.59 2.6 4.326 4.641 4.706
    Accumulated Depreciation, Total -1.711 -1.471 -3.602 -3.914 -3.57
    Other Long Term Assets, Total 1.536 0.875 1.554 1.225 1.816
    Total Current Liabilities 5.819 4.078 4.729 3.591 3.261
    Accounts Payable 1.641 1.769 2.067 1.255 1.272
    Accrued Expenses 1.309 1.027 1.446 1.236 1.023
    Notes Payable/Short Term Debt 0.688 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.12 0.596 0.481 0.463 0.377
    Other Current Liabilities, Total 2.061 0.686 0.735 0.637 0.589
    Total Liabilities 10.148 9.624 8.937 3.959 3.88
    Total Long Term Debt 0 1.31 0 0.012 0.176
    Long Term Debt 0 1.31 0 0.012 0.032
    Capital Lease Obligations 0 0.144
    Other Liabilities, Total 4.329 4.236 4.208 0.356 0.443
    Total Equity 8.697 5.363 5.624 10.489 15.326
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.002 0.002 0.002 0.002 0.001
    Additional Paid-In Capital 197.37 189.217 186.559 184.074 176.74
    Retained Earnings (Accumulated Deficit) -184.363 -179.277 -175.327 -169.238 -157.44
    Other Equity, Total -4.312 -4.579 -5.61 -4.349 -3.975
    Total Liabilities & Shareholders’ Equity 18.845 14.987 14.561 14.448 19.206
    Total Common Shares Outstanding 3.10094 2.09291 1.77748 1.31634 0.68575
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    流动资产总额 11.232 12.393 14.817 16.43 17.699
    现金和短期投资 2.634 3.351 5.586 7.396 8.529
    现金等价物 2.634 3.351 5.586 7.396 8.529
    应收账款总额，净额 2.297 2.487 2.434 2.407 2.854
    Accounts Receivable - Trade, Net 2.297 2.487 2.434 2.407 2.854
    Total Inventory 2.849 3.025 2.788 2.663 2.879
    Prepaid Expenses 3.23 3.315 3.794 3.746 3.226
    Other Current Assets, Total 0.222 0.215 0.215 0.218 0.211
    Total Assets 13.928 14.962 17.158 18.845 19.347
    Property/Plant/Equipment, Total - Net 0.785 0.835 0.787 0.879 0.922
    Other Long Term Assets, Total 1.911 1.734 1.554 1.536 0.726
    Total Current Liabilities 3.934 3.527 4.854 5.819 3.875
    Accounts Payable 1.302 1.074 2.057 1.641 1.583
    Accrued Expenses 2.477 2.071 2.185 2.093 1.553
    Notes Payable/Short Term Debt 0 0.229 0.459 0.688 0
    Current Port. of LT Debt/Capital Leases 0 0 0 0.12 0.587
    Other Current Liabilities, Total 0.155 0.153 0.153 1.277 0.152
    Total Liabilities 8.369 7.941 9.199 10.148 8.178
    Total Long Term Debt 0.015 0.015 0.015 0 0
    Long Term Debt 0.015 0.015 0.015 0 0
    Other Liabilities, Total 4.42 4.399 4.33 4.329 4.303
    Total Equity 5.559 7.021 7.959 8.697 11.169
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.002 0.002 0.002 0.002 0.003
    Additional Paid-In Capital 197.939 197.697 197.584 197.37 197.156
    Retained Earnings (Accumulated Deficit) -188.206 -186.267 -185.25 -184.363 -181.419
    Other Equity, Total -4.176 -4.411 -4.377 -4.312 -4.571
    Total Liabilities & Shareholders’ Equity 13.928 14.962 17.158 18.845 19.347
    Total Common Shares Outstanding 3.10965 3.10297 3.10094 3.10094 3.09934
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -5.086 -3.95 -2.946 -11.798 -14.328
    经营活动产生的现金 -4.248 -3.378 -4.591 -11.717 -12.439
    经营活动产生的现金 0.186 0.227 0.312 0.453 0.49
    非现金物品 -1.873 -1.039 -0.398 0.894 3.151
    已付现金利息 0.024 0.012 0.016 0.033 0.04
    营运资金的变化 3.354 1.384 -1.559 -1.266 -1.752
    投资活动产生的现金 -0.099 0.388 3.644 -0.131 -0.201
    资本支出 -0.137 -0.179 -0.206 -0.1 -0.187
    其他投资现金流量项目，总计 0.038 0.567 3.85 -0.031 -0.014
    融资活动产生的现金 7.396 3.308 1.029 5.492 5.24
    股票的发行（报废），净额 7.77 2.287 1.376 5.97 5.52
    债务的发行（退还），净额 -0.374 1.021 -0.347 -0.478 -0.28
    外汇效应 0.127 0.211 -0.08 -0.021 0.005
    现金净变化 3.176 0.529 0.002 -6.377 -7.395
    Cash Taxes Paid 0.767 0.941
    Deferred Taxes -0.829
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -3.843 -1.904 -0.887 -5.086 -2.142
    Cash From Operating Activities -3.711 -3.363 -1.533 -4.248 -2.853
    Cash From Operating Activities 0.091 0.059 0.031 0.186 0.137
    Non-Cash Items 0.568 0.327 0.214 -1.873 -0.703
    Cash Interest Paid 0.012 0.008 0.004 0.024 0.012
    Changes in Working Capital -0.284 -1.706 -0.851 3.354 -0.145
    Cash From Investing Activities -0.176 -0.21 -0.023 -0.099 -0.038
    Capital Expenditures -0.079 -0.048 -0.023 -0.137 -0.075
    Other Investing Cash Flow Items, Total -0.097 -0.162 0.038 0.037
    Cash From Financing Activities -0.883 -0.565 -0.387 7.396 7.174
    Issuance (Retirement) of Stock, Net 0 0 7.77 7.77
    Issuance (Retirement) of Debt, Net -0.794 -0.565 -0.35 -0.374 -0.596
    Foreign Exchange Effects 0.008 0.093 0.133 0.127 0.026
    Net Change in Cash -4.762 -4.045 -1.81 3.176 4.309
    Financing Cash Flow Items -0.089 -0.037
    Deferred Taxes -0.243 -0.139 -0.04 -0.829
    Cash Taxes Paid 0.055
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Renaissance Technologies LLC Hedge Fund 0.9027 41967 -32500 2023-03-31 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7789 36214 -541 2023-03-31 LOW
    Millennium Management LLC Hedge Fund 0.507 23574 6974 2023-03-31 HIGH
    Virtu Americas LLC Research Firm 0.3456 16068 16068 2023-03-31 HIGH
    Ground Swell Capital, LLC Investment Advisor 0.2867 13329 13329 2023-03-31 HIGH
    Tower Research Capital LLC Hedge Fund 0.1845 8580 520 2023-03-31 HIGH
    Birnbaum (Jay E) Individual Investor 0.1234 5739 0 2022-07-22
    McLaughlin (Jerry G.) Individual Investor 0.1164 5414 0 2022-07-22
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.0618 2875 0 2023-03-31 LOW
    Advisory Services Network, LLC Investment Advisor 0.053 2463 2463 2023-03-31 LOW
    Thornton (Bruce) Individual Investor 0.0177 825 0 2022-07-22
    JPMorgan Private Bank (United States) Bank and Trust 0.0145 672 672 2023-03-31 LOW
    U.S. Bancorp Asset Management, Inc. Investment Advisor 0.0108 500 0 2023-03-31 LOW
    Advisor Group, Inc Investment Advisor 0.0046 216 50 2023-03-31 LOW
    Morgan Stanley Smith Barney LLC Investment Advisor 0.0018 86 0 2023-03-31 LOW
    Allworth Financial, L.P. Investment Advisor 0.0014 65 0 2023-03-31 LOW
    BofA Global Research (US) Research Firm 0.0009 44 0 2023-03-31 LOW
    Gradient Investments LLC Investment Advisor 0.0007 31 0 2023-03-31 MED
    Wells Fargo Bank, N.A. Bank and Trust 0.0005 21 0 2023-03-31 LOW
    NewSquare Capital LLC Investment Advisor 0.0002 10 0 2023-03-31 MED

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Sonoma Pharma Company profile

    关于 Sonoma Pharma

    Sonoma Pharmaceuticals, Inc.从事开发和生产次氯酸（HOCl）产品，其应用范围包括伤口护理、动物保健、眼睛护理、口腔护理和皮肤病。 该公司的产品包括Epicyn抗菌洁面乳、Levicyn抗菌皮肤喷雾剂、Levicyn止痒凝胶、Levicyn止痒喷雾凝胶、Celacyn疤痕管理凝胶和Sebuderm外用凝胶。 其产品主要针对痤疮的治疗、疤痕管理和特应性皮炎。 它还有办公室配药产品，如Lasercyn Dermal Spray、Lasercyn Post Procedure Gel和Regenacyn Advanced Scar Management。 该公司直接或通过合作伙伴在全球约54个国家销售其产品。 其子公司包括Aquamed Technologies, Inc., Oculus Technologies of Mexico, S.A. de C.V. 和Sonoma Pharmaceuticals Netherlands B.V.。

    Industry: Pharmaceuticals (NEC)

    5445 Conestoga Court, Suite 150
    BOULDER
    COLORADO 80301
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    XRP/USD

    0.53 Price
    -0.410% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00400

    BTC/USD

    27,319.70 Price
    +0.410% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    US100

    14,557.80 Price
    +0.640% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 3.0

    Gold

    1,948.36 Price
    -1.480% 1D Chg, %
    多头隔夜费 -0.0185%
    空头隔夜费 0.0103%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易